...
首页> 外文期刊>Genome research >Genome-wide discovery of active regulatory elements and transcription factor footprints in Caenorhabditis elegans using DNase-seq
【24h】

Genome-wide discovery of active regulatory elements and transcription factor footprints in Caenorhabditis elegans using DNase-seq

机译:使用DNASE-SEQ的Caenorhabditis elegans中的基因组发现活跃调节元件和转录因子足迹

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Deep sequencing of size-selected DNase I-treated chromatin (DNase-seq) allows high-resolution measurement of chromatin accessibility to DNase I cleavage, permitting identification of de novo active cis-regulatory modules (CRMs) and individual transcription factor (TF) binding sites. We adapted DNase-seq to nuclei isolated from C. elegans embryos and L1 arrest larvae to generate high-resolution maps of TF binding. Over half of embryonic DNase I hypersensitive sites (DHSs) were annotated as noncoding, with 24% in intergenic, 12% in promoters, and 28% in introns, with similar statistics observed in L1 arrest larvae. Noncoding DHSs are highly conserved and enriched in marks of enhancer activity and transcription. We validated noncoding DHSs against known enhancers from myo-2, myo-3, hlh-1, elt-2, and lin-26/lir-1 and recapitulated 15 of 17 known enhancers. We then mined DNase-seq data to identify putative active CRMs and TF footprints. Using DNase-seq data improved predictions of tissue-specific expression compared with motifs alone. In a pilot functional test, 10 of 15 DHSs from pha-4, icl-1, and ceh-13 drove reporter gene expression in transgenic C. elegans. Overall, we provide experimental annotation of 26,644 putative CRMs in the embryo containing 55,890 TF footprints, as well as 15,841 putative CRMs in the L1 arrest larvae containing 32,685 TF footprints.
机译:尺寸选择的DNA酶I处理的染色质(DNASE-SEQ)的深度测序允许高分辨率测量染色质可用性对DNA酶I切割,允许鉴定DE Novo有源顺式调节模块(CRM)和单个转录因子(TF)结合网站。我们将DNase-SEQ调整为从C.杆状杆菌胚胎和L1抑制幼虫分离的核,以产生高分辨率的TF结合映射。超过一半的胚胎DNA酶I过敏位点(DHSS)被注释为非码,在仲裁剂中具有24%,促进剂12%,内含子28%,在L1抑制幼虫中观察到类似的统计数据。非成型DHSS在增强剂活动和转录的标志中高度保守和富集。我们从MyO-2,MyO-3,HLH-1,ELT-2和LIN-26 / LiR-1中验证了针对已知增强剂的非分量DHSS,并重新携带17个已知增强剂的15个。然后我们开采DNASE-SEQ数据以识别推定的活性CRM和TF占地面积。使用DNASE-SEQ数据改进了组织特异性表达的预测,与单独的基序相比。在试验功能试验中,来自PHA-4,ICL-1和CEH-13的10个中的10个,其​​中在转基因C.杆状此开发了报告者基因表达。总体而言,我们在含有55,890汤匙足迹的胚胎中提供26,644个推定CRM的实验注释,以及含有32,685个TF占地面积的L1捕获幼虫的15,841个推定CRM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号